AccuGenomics develops of a unique spike-in control technology that improves the accuracy & performance of clinical sequencing tests.
AccuGenomics develops spike-in internal standards, sold as SNAQ-SEQ, that improve the accuracy of clinical sequencing tests. They are used in applications such as ctDNA, copy number variant and biocontaminant testing, and were used for COVID-19.
AccuGenomics was founded in 2010 by James Willey.
Traffic estimates from Semrush, latest month.
Source: company website, checked 2026-10-30.
Search verified work emails and direct dials for people at accugenomics.com.
Or explore the full B2B database and filter by biotechnology companies.